Scarica l'app Stockscreener
331.00
2.21%
-7.48
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$338.48
Aprire:
$337.15
Volume 24 ore:
1.17M
Relative Volume:
0.92
Capitalizzazione di mercato:
$63.16B
Reddito:
$328.68B
Utile/perdita netta:
$2.55B
Rapporto P/E:
25.39
EPS:
13.0349
Flusso di cassa netto:
$1.56B
1 W Prestazione:
-2.91%
1M Prestazione:
+5.99%
6M Prestazione:
+6.30%
1 anno Prestazione:
+0.74%
Intervallo 1D:
$330.31
$338.07
Intervallo di 1 settimana:
$330.31
$345.00
Portata 52W:
$244.82
$377.54
Cencora Inc Stock (COR) Company Profile
Nome
Cencora Inc
Settore
Industria
Telefono
610-727-7000
Indirizzo
1 WEST FIRST AVENUE, CONSHOHOCKEN
Compare COR vs MCK, CAH, HSIC, AHG
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
COR
Cencora Inc
|
331.00 | 63.16B | 328.68B | 2.55B | 1.56B | 13.03 |
MCK
Mckesson Corp
|
1,000.77 | 116.68B | 403.43B | 5.10B | 5.41B | 38.47 |
CAH
Cardinal Health Inc
|
249.57 | 57.79B | 250.74B | 1.55B | 4.39B | 6.5398 |
HSIC
Henry Schein Inc
|
84.96 | 9.47B | 13.38B | 418.00M | 391.00M | 3.3112 |
AHG
Akso Health Group Adr
|
1.30 | 1.11B | 14.85M | -136.07M | 7.25M | -0.4726 |
Cencora Inc Stock (COR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-08-19 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2026-04-28 | Iniziato | William Blair | Mkt Perform |
| 2026-01-29 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2026-01-22 | Aggiornamento | Jefferies | Hold → Buy |
| 2025-12-09 | Iniziato | Barclays | Overweight |
| 2025-06-03 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2024-12-04 | Ripresa | Mizuho | Outperform |
| 2024-09-18 | Downgrade | BofA Securities | Buy → Neutral |
| 2024-02-26 | Iniziato | Leerink Partners | Outperform |
| 2024-01-03 | Iniziato | Barclays | Overweight |
| 2023-12-14 | Iniziato | Wells Fargo | Equal Weight |
| 2023-03-31 | Iniziato | Citigroup | Buy |
| 2023-01-31 | Ripresa | Evercore ISI | Outperform |
| 2022-10-11 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2022-08-22 | Ripresa | Morgan Stanley | Equal-Weight |
| 2022-07-11 | Downgrade | Evercore ISI | Outperform → In-line |
| 2022-06-07 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2022-05-26 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2022-04-12 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-04-01 | Ripresa | Credit Suisse | Outperform |
| 2021-03-12 | Ripresa | Evercore ISI | In-line |
| 2021-02-04 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2021-02-02 | Aggiornamento | Cowen | Market Perform → Outperform |
| 2021-01-06 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2021-01-06 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2020-12-10 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| 2020-12-03 | Iniziato | Mizuho | Neutral |
| 2020-08-06 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2020-07-15 | Iniziato | Barclays | Underweight |
| 2020-06-15 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2020-04-23 | Ripresa | Credit Suisse | Outperform |
| 2020-04-16 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2020-04-13 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2020-04-01 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2020-03-17 | Aggiornamento | Citigroup | Neutral → Buy |
| 2020-02-11 | Downgrade | BofA/Merrill | Buy → Underperform |
| 2020-02-07 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2019-09-12 | Iniziato | Deutsche Bank | Hold |
| 2019-07-10 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2019-04-11 | Iniziato | Guggenheim | Buy |
| 2019-04-10 | Downgrade | BofA/Merrill | Buy → Underperform |
| 2019-04-10 | Downgrade | Evercore ISI | Outperform → In-line |
| 2019-02-11 | Downgrade | JP Morgan | Neutral → Underweight |
| 2019-01-17 | Iniziato | UBS | Buy |
| 2018-12-10 | Downgrade | Jefferies | Buy → Hold |
| 2018-10-26 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2018-09-20 | Iniziato | Berenberg | Buy |
| 2018-07-17 | Ripresa | Stifel | Hold |
| 2018-04-09 | Iniziato | MoffettNathanson | Buy |
| 2018-03-12 | Aggiornamento | KeyBanc Capital Mkts | Sector Weight → Overweight |
| 2018-03-12 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2017-09-25 | Iniziato | JP Morgan | Neutral |
| 2017-09-22 | Iniziato | William Blair | Outperform |
Mostra tutto
Cencora Inc Borsa (COR) Ultime notizie
Pharma Pulse: Cencora to Acquire AON, Amazon and Google Back ePA Expansion - Pharmaceutical Commerce
4 Firms Steer Cencora's $2.4B American Oncology Acquisition - Law360
Cencora making $2.4B acquisition as diversification push continues - The Business Journals
Cencora, Inc. (COR) Stock Forecasts - Yahoo Finance
Deals tracker: Harbor Health to buy 27 Village Medical clinics - Modern Healthcare
Here’s How Much You Would Have Made Owning Cencora Stock In The Last 5 Years - Benzinga
Cencora (COR) to Acquire American Oncology Network in $2.4B Deal - GuruFocus
Cencora, Inc. signed a definitive agreement to acquire remaining 96% stake in American Oncology Network, Inc. from AEA Growth Equity Fund LP, managed by AEA Investors LP and others. - marketscreener.com
Form 8K Cencora Inc For: 21 October By Investing.com - Investing.com Nigeria
Cencora (COR) Agrees to Acquire American Oncology Network in $2. - GuruFocus
Cencora to Acquire American Oncology Network in $2.4 Billion Deal - citybiz
Cencora to buy cancer care provider American Oncology Network in $2.4B deal - Seeking Alpha
Cencora to acquire American Oncology Network for $2.4 billion - Investing.com
Cencora to acquire American Oncology Network in $2.4 billion deal - Yahoo Finance
Cencora to Acquire American Oncology Network to Strengthen Support of Community Oncology - Yahoo Finance
Amgen vs. Bristol Myers Squibb: Which Healthcare Stock Is a Better Buy in 2026? - The Motley Fool
Cencora stock: Cencora schedules November 4 results for Cencora stock - ad-hoc-news.de
Cencora, Inc. (COR) Stock Forecasts - Yahoo Finance
Cencora stock price target raised to $380 by Argus on growth outlook - Investing.com Canada
Cencora stock price target raised to $380 by Argus on growth outlook - Investing.com
26 ETFs Add to Cencora (COR) Holdings on Oct. 16 - Yahoo Finance
Cencora Inc Lobbying Profile, 2006 - OpenSecrets
UBS cuts target to USD 400 for Cencora stock - ad-hoc-news.de
Cencora Inc. stock: drug distributor at EUR 303.60 ahead of the Xetra open - ad-hoc-news.de
Cencora stock: A 25.36 P/ E gives Cencora stock a valuation anchor - ad-hoc-news.de
Cencora stock trades at EUR 302.00 ahead of quarterly results - ad-hoc-news.de
Cencora Inc. Common Stock (COR) Company Profile - Pluang
ABC5748091 Bond Profile: Coupon and Redemption - TradingView
ABC6310086 Bond Profile: Coupon and Redemption - TradingView
Cencora (COR): 3 Reasons We Love This Stock - Yahoo Finance
Is Cencora (COR) Undervalued Or Is Raised Guidance Already Priced In? - Yahoo Finance
Cencora stock pre-market at EUR 304.65 - ad-hoc-news.de
Cencora Inc. stock outperforms competitors on strong trading day - MarketWatch
Cencora, Inc. (COR) Stock Forecasts - Yahoo! Finance Canada
AbbVie vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026? - The Motley Fool
Fund Update: 185,057 CENCORA (COR) shares added to FORT WASHINGTON INVESTMENT ADVISORS INC |OH| portfolio - Quiver Quantitative
Baird raises target for Cencora stock to USD 373.00 - ad-hoc-news.de
Cencora, Inc. (COR) Stock Forecasts - Yahoo Finance
Cencora Inc. stock outperforms competitors on strong trading day - MarketWatch
Cencora Currently Up Eight Days Straight, On Pace for Longest Winning Streak Since January 2025 -- Data Talk - Moomoo
AI Disruption May Benefit Cencora More Than Hims & Hers (NYSE:COR) - Seeking Alpha
Cencora Inc. stock outperforms competitors on strong trading day - MarketWatch
Cencora stock trades at EUR 291.90 with USD 63.3 billion value - ad-hoc-news.de
XS307124629 Bond Profile: Coupon and Redemption - TradingView
Cencora (COR) Has Investors Asking A Bigger Question - Simply Wall Street
Cencora appointed Robert Sanchez as analysts cite USD 372.07 target for Cencora stock - ad-hoc-news.de
US03073EBF16 Bond Profile: Coupon and Redemption - TradingView
ABC4571977 Bond Profile: Coupon and Redemption - TradingView
Cencora, Inc. (COR) Options Chain - Yahoo! Finance Canada
Cencora Inc. stock outperforms competitors on strong trading day - MarketWatch
Cencora Inc Azioni (COR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Cencora Inc Azioni (COR) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| GREENBERG LON R | Director |
Sep 16 '26 |
Sale |
321.30 |
1,280 |
411,264 |
17,128 |
| Lon Greenberg | Director |
Sep 16 '26 |
Proposed Sale |
321.31 |
1,280 |
411,282 |
0 |
| Battaglia Silvana | Former Officer |
Sep 11 '26 |
Proposed Sale |
325.00 |
1,324 |
430,300 |
0 |
| Cleary James F | Former Officer |
Sep 04 '26 |
Proposed Sale |
335.17 |
10,000 |
3,351,656 |
0 |
| Krikorian Lazarus | SVP & Chief Accounting Officer |
Sep 01 '26 |
Sale |
325.97 |
985 |
321,080 |
16,169 |
| Battaglia Silvana | Former Officer |
Sep 01 '26 |
Proposed Sale |
330.00 |
6,593 |
2,175,690 |
0 |
| Campbell Elizabeth S | Executive Vice President |
Aug 24 '26 |
Sale |
324.12 |
11,300 |
3,662,663 |
19,455 |
| Campbell Elizabeth S | Officer |
Aug 24 '26 |
Proposed Sale |
324.10 |
11,301 |
3,662,663 |
0 |
| Cleary James F | Officer |
Aug 06 '26 |
Proposed Sale |
316.65 |
20,000 |
6,333,096 |
0 |
| Tyler Lauren M | Director |
Jun 22 '26 |
Buy |
270.23 |
550 |
148,626 |
4,359 |
2.37%
6.56%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):